Sinotherapeutics, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -15.55% vs 1.08% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -7.26% vs -28.69% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "94.50",
          "val2": "111.90",
          "chgp": "-15.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.60",
          "val2": "13.00",
          "chgp": "12.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.60",
          "val2": "17.90",
          "chgp": "-7.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "154.20%",
          "val2": "116.30%",
          "chgp": "3.79%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 70.58% vs 21.13% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 109.00% vs -34.23% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "511.40",
          "val2": "299.80",
          "chgp": "70.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "144.00",
          "val2": "66.70",
          "chgp": "115.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "127.70",
          "val2": "61.10",
          "chgp": "109.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "231.90%",
          "val2": "142.40%",
          "chgp": "8.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Sep'25

Change(%)

Net Sales

94.50

111.90

-15.55%

Operating Profit (PBDIT) excl Other Income

14.60

13.00

12.31%

Interest

0.00

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

16.60

17.90

-7.26%

Operating Profit Margin (Excl OI)

154.20%

116.30%

3.79%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -15.55% vs 1.08% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -7.26% vs -28.69% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

511.40

299.80

70.58%

Operating Profit (PBDIT) excl Other Income

144.00

66.70

115.89%

Interest

0.10

0.10

Exceptional Items

0.00

-1.10

100.00%

Consolidate Net Profit

127.70

61.10

109.00%

Operating Profit Margin (Excl OI)

231.90%

142.40%

8.95%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 70.58% vs 21.13% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 109.00% vs -34.23% in Dec 2023

All Annual Results